The role of immune surveillance in malignant transformation of benign salivary gland tumors Journal Article


Authors: Linxweiler, M.; Wang, J.; Morris, L. G. T.
Article Title: The role of immune surveillance in malignant transformation of benign salivary gland tumors
Abstract: Pleomorphic adenoma (PA), the most common salivary gland tumor, is a benign tumor that carries a risk of malignant transformation to various histologies of carcinoma ex pleomorphic adenoma (CA exPA). Recently, genomic analyses have provided deeper insights into the molecular biology of salivary gland cancers. However, the molecular processes that underlie the progression from PA to CA exPA are largely unknown. In this study, we used RNAseq data from CA ex PA of myoepithelial (n = 24) or salivary duct histology (n = 6), de novo myoepithelial carcinoma (n = 16) and de novo salivary duct carcinoma (n = 10), and compared their constituent immune tumor microenvironments. We found that increasing levels of immune infiltration and activation were associated with a generally lower probability of cancer developing ex-PA, suggesting that immune surveillance may constrain the malignant transformation of benign salivary tumors. More immunologically infiltrated tumors were more likely to have developed de novo. Taken together, these data suggest a role for tumor escape from immune surveillance in the development of CA exPA. The immune-cold microenvironments of CA ex PA tumors may in part explain their more aggressive clinical behavior. Copyright: © 2021 Linxweiler et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: immune surveillance; pleomorphic adenoma; salivary cancer; salivary tumor
Journal Title: Oncotarget
Volume: 12
Issue: 7
ISSN: 1949-2553
Publisher: Impact Journals  
Date Published: 2021-03-30
Start Page: 592
End Page: 595
Language: English
DOI: 10.18632/oncotarget.27900
PROVIDER: scopus
PMCID: PMC8021028
PUBMED: 33868581
DOI/URL:
Notes: Article -- Export Date: 1 June 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Luc Morris
    278 Morris
  2. Jingming Wang
    8 Wang